Tune in for a compelling journey into precision medicine with Sheryl Elkin, PhD, the Chief Scientific Officer for QIAGEN. She shares the importance of precision medicine, technical advancements in cancer treatment, and QIAGEN's role in making it accessible. Explore the industry's challenges and solutions. Gain insights into precision medicine. Listen now!

Ready for an extraordinary journey in accessible & affordable fertility care? Tune in to our latest episode of the SciMed Biotech Podcast with Traci Keen, CEO of Mate Fertility, and explore their mission to revolutionize fertility treatment.

In this SciMed Biotech Podcast episode, meet Dr. Marvella Ford, a prominent figure in cancer research and health equity. Explore her journey from Cornell to impactful research at the University of Michigan. Discover her pioneering work in reducing cancer health disparities and her NCI Partnerships to Advance Cancer Health Equity grant. With 117+ peer-reviewed papers and editorial roles, she's transforming cancer care. Join us for inspiration from a barrier-breaker in science and the community.

Join us on the latest episode of the SciMed Biotech Podcast as we dive into the future of healthcare finances with Akash Magoon, the Co-Founder and CEO of Adonis. Discover how Adonis is leveraging technology to bring transparency and efficiency to healthcare payments.

Explore the future of personalized medicine on the SciMed Biotech Podcast with Rafael Rosengarten, Co-Founder and CEO of Genialis. Join us for a conversation where Rafael reveals how Genialis is revolutionizing the drug discovery process with data science.

Join us on the SciMed Biotech Podcast with Ecovative's Gavin McIntyre to explore the wonders of mycelium. From ancient origins to modern solutions, discover how mycelium is reshaping sustainability, battling single-use plastics, and sparking innovation.

Explore precision drug delivery and the future of medicine with Steven Rosenzweig. Discover innovation in targeted therapies, ethical considerations, and more.

Dive into the future of cancer treatment in this episode of the SciMed Podcast with David Feltquate, Chief Medical Officer at Palleon Pharmaceuticals.

In our latest podcast episode, we sit down with Rom Cohen, the CIO and co-founder of Hyro, a company on a mission to transform the way we communicate with technology.

Brace yourself for an exhilarating journey into the world of cutting-edge cancer immunotherapy with Dr. Joanna Brewer, Chief Scientific Officer of Adaptimmune!

Dive into the future of healthcare with us! In our latest electrifying episode of the SciMed podcast, we had the honor of hosting the trailblazing CEO of Mend Labs, Eziah Syed.

In this Q&A article, Caroline - the latest addition to the SciMed team - shares more about her summer internship experience at SciMed, her passion for computer science, and her hopes for the future.

In this episode, Dr. Varner takes us on a journey into the world of cancer research, unraveling insights that could shape the future of cancer treatment.

In this episode, Adam Stasio speaks with Jay West from BioSkryb about their innovative ResolveDNA® technology and how it has ushered in a new era of single-cell whole genome amplification.

In this episode, host Adam Stasio interviews Jim McNally - Chief Scientific Officer at BioAgilytix - a leading expert in bioanalytical assay development and program leadership.

In this episode of the SciMed Biotech podcast, Adam Stasio sits down with Fred Ashbury, co-founder and Chief Scientific Officer at VieCure, a cancer company with a wealth of experience in cancer care.

Product development is no easy task. To consistently develop and launch great products, you need a repeatable and scalable process. In this article, we offer 5 frameworks to evaluate opportunities, prioritize features, and define the final product.

No one doubts that the stock market has been taking hit after hit for the past year, with the Nasdaq 100 dropping nearly 33%. But, if you look closely enough, you might see a sliver of hope: the biotechnology sector.

Biotech’s sudden uptick doesn’t come as a surprise, however. As the economy takes a downturn, there are a few reasons why analysts and investors think biotech will soar throughout the recession.

User testing is a critical component of software development, especially in the pharmaceutical and other life science industries. There are many reasons why user testing is so important in developing software. In this article, we’ll only focus on the three we consider most important.

Every biotechnology company working hard to change the world has its own set of unique challenges. This means that when it comes to developing software, they’ll need a unique solution tailored to their needs. In this article, we dive into everything you should know that could impact the cost of building a software solution for your business.